Global Phycoerythrin Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Phycoerythrin Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Phycoerythrin (PE) is a red protein-pigment complex from the light-harvesting phycobiliprotein family, present in red algae and cryptophytes, accessory to the main chlorophyll pigments responsible for photosynthesis. Phycoerythrin (PE) is a red protein-pigment complex from the light-harvesting phycobiliprotein family, present in red algae and cryptophytes, accessory to the main chlorophyll pigments responsible for photosynthesis. Like all phycobiliproteins, it is composed of a protein part covalently binding chromophores called phycobilin.

Market Overview:

The latest research study on the global Phycoerythrin market finds that the global Phycoerythrin market reached a value of USD 14.79 million in 2022. It’s expected that the market will achieve USD 20.67 million by 2028, exhibiting a CAGR of 5.74% during the forecast period.

Region Overview:

From 2023-2028, United States is estimated to witness robust growth prospects.

Company Overview:

The top three companies are Agilent Technologies, Algapharma Biotech Corporation and Phyco-Biotech with the revenue market share of 16.28%, 13.56% and 9.13% in 2019.

Agilent Technologies is an American public research, development and manufacturing company established in 1999 as a spin-off from Hewlett-Packard. The resulting IPO of Agilent stock was the largest in the history of Silicon Valley at the time.

The Agilent R-Phycoerythrin (R-PE) Coupling Kit (formerly ProZyme) contains everything needed to couple up to 1 mg (approximately 1000 detections) of antibody to RPE. Includes a complete step-by-step procedure for small-scale coupling (as low as 50 µg antibody).

Algapharma Biotech Corp. with world-leading expertise in large-scale microalgae cultivation from Far East Microalgae Co, Ltd, holds the core technology in bulk protein production, purification and conjugation.

Algapharma Biotech Corporation Phycobiliproteins are stable and water-soluble proteins derived from cyanobacteria and certain algae. Shipped with ice pack as a suspension in 100 mM Potassium Phosphate buffer, pH7.0 with 60 % Saturated (NH4)2SO4, 1 mM EDTA and 1 mM Sodium Azide. They are stable when stored at 2 ~ 8°C for at least three year.

Segmentation Overview:

Among different product types, R-phycoerythrin segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Medical segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Phycoerythrin market covered in Chapter 3:

Phyco-Biotech
Eurogentec
Jackson ImmunoResearch Laboratories, Inc.
Columbia Biosciences Corporation
Thermo Fisher Scientific
Algapharma Biotech Corporation
Agilent Technologies
Sigma-Aldrich Corporation
Shanghai Laya Biotechnology Co., Ltd.
SETA BioMedicals
AAT Bioquest, Inc.

In Chapter 4 and Chapter 14.2, on the basis of types, the Phycoerythrin market from 2018 to 2029 is primarily split into:

PE545
R-phycoerythrin
B-phycoerythrin
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Phycoerythrin market from 2018 to 2029 covers:

Scientific Research
Medical
Cosmetic
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)